Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Kidney-Targeted Epoxyeicosatrienoic Acid Analog, EET-F01, Reduces Inflammation, Oxidative Stress, and Cisplatin-Induced Nephrotoxicity
John D. Imig, Abdul H. Khan, Anna Burkhan, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 2793-2793
Open Access | Times Cited: 17

Showing 17 citing articles:

Application of Approved Cisplatin Derivatives in Combination Therapy against Different Cancer Diseases
Dobrina Tsvetkova, Stefka Ivanova
Molecules (2022) Vol. 27, Iss. 8, pp. 2466-2466
Open Access | Times Cited: 63
Direct targeting of sEH with alisol B alleviated the apoptosis, inflammation, and oxidative stress in cisplatin-induced acute kidney injury
Juan Zhang, Zhilin Luan, Xiaokui Huo, et al.
International Journal of Biological Sciences (2022) Vol. 19, Iss. 1, pp. 294-310
Open Access | Times Cited: 43
Docosahexaenoic acid-acylated curcumin diester alleviates cisplatin-induced acute kidney injury by regulating the effect of gut microbiota on the lipopolysaccharide- and trimethylamine-N-oxide-mediated PI3K/Akt/NF-κB signaling pathway in mice
Teruyoshi Yanagita, Lipin Chen, Chengcheng Wang, et al.
Food & Function (2022) Vol. 13, Iss. 11, pp. 6103-6117
Closed Access | Times Cited: 25
Effects of Epoxyeicosatrienoic Acid-Enhancing Therapy on the Course of Congestive Heart Failure in Angiotensin II-Dependent Rat Hypertension: From mRNA Analysis towards Functional In Vivo Evaluation
Petr Kala, Matúš Miklovič, Šárka Jíchová, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 1053-1053
Open Access | Times Cited: 17
Multi-Target Drugs for Kidney Diseases
John D. Imig, Daniel Merk, Eugen Proschak
Kidney360 (2021) Vol. 2, Iss. 10, pp. 1645-1653
Open Access | Times Cited: 15
Nephrotoxicity in cancer treatment: An update
Chaoling Chen, Dengpiao Xie, David A. Gewirtz, et al.
Advances in cancer research (2022), pp. 77-129
Closed Access | Times Cited: 9
Receptor of Advanced Glycation End Products Deficiency Attenuates Cisplatin-Induced Acute Nephrotoxicity by Inhibiting Apoptosis, Inflammation and Restoring Fatty Acid Oxidation
Qiang Wang, Yuemei Xi, Binyang Chen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
The value of lipid metabolites 9,10-DOA and 11,12-EET in prenatal diagnosis of fetal heart defects
Yiwei Fang, Zheng Zhang, Yun Zhao, et al.
Clinica Chimica Acta (2023) Vol. 544, pp. 117330-117330
Closed Access | Times Cited: 3
TPPU Downregulates Oxidative Stress Damage and Induces BDNF Expression in PC-12 Cells
Qiong Wu, Minlin Lin, Peng Wu, et al.
Computational and Mathematical Methods in Medicine (2022) Vol. 2022, pp. 1-7
Open Access | Times Cited: 5
Epoxyeicosatrienoic acid administration or soluble epoxide hydrolase inhibition attenuates renal fibrogenesis in obstructive nephropathy
Mi Ra Noh, Hee‐Seong Jang, Fadi Salem, et al.
AJP Renal Physiology (2022) Vol. 324, Iss. 2, pp. F138-F151
Open Access | Times Cited: 5
New Alkoxy- Analogues of Epoxyeicosatrienoic Acids Attenuate Cisplatin Nephrotoxicity In Vitro via Reduction of Mitochondrial Dysfunction, Oxidative Stress, Mitogen-Activated Protein Kinase Signaling, and Caspase Activation
Nalin Singh, Anders Vik, Daniel B. Lybrand, et al.
Chemical Research in Toxicology (2021) Vol. 34, Iss. 12, pp. 2579-2591
Open Access | Times Cited: 5
Nephro- and Cardiotoxic Effects of Etoricoxib: Insights into Arachidonic Acid Metabolism and Beta-Adrenergic Receptor Expression in Experimental Mice
Yahya F. Jamous, Badrah S. Alghamdi, Yazun Jarrar, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1454-1454
Open Access
Vasoactive Substances as Mediators of Renal Injury
Paulo S. Caceres, Noreen F. Rossi
Elsevier eBooks (2024)
Closed Access
Soluble Epoxide Hydrolase Inhibition Attenuates Proteinuria by Alleviating Renal Inflammation and Podocyte Injuries in Adriamycin-Induced Nephropathy
Qingyu Niu, Ziyu Guo, Yaoxian Liang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10629-10629
Open Access
The Immune System in Nephrotoxicity
John D. Imig, Samaneh Goorani, Abhishek Mishra
Elsevier eBooks (2024)
Closed Access
Orally active epoxyeicosatrienoic acid analogs in hypertension and renal injury
John D. Imig
Advances in pharmacology (2022), pp. 27-55
Open Access | Times Cited: 2
Synthesis and Antitumor Activity of (3-Hydroxyacrylato-O,O′) Diammineplatinum(II)
Yong-Zhi Shu, Jun Lin, Zhu Bao-quan, et al.
Pharmaceutical Fronts (2021) Vol. 03, Iss. 01, pp. e13-e17
Open Access | Times Cited: 1
Page 1

Scroll to top